Contact
Please use this form to send email to PR contact of this press release:
Altis Labs Announces Presentation of Results at ASCO 2025: IPRO-Δ Outperforms RECIST in Predicting OS in Ph 3 Trial
TO:
Felix Baldauf-Lenschen
Altis Labs, Inc.